London, UK: Alma Fertility has announced a new international partnership with The Medical Travel Company (TMTC), creating a coordinated UK–India pathway for patients considering donor egg treatment.

The partnership brings together Alma Fertility’s personalised fertility care in London with TMTC’s international treatment pathway in India, giving patients access to expert guidance and support from their initial consultation through treatment planning, donor coordination and treatment.

For some patients, donor egg treatment can be an important option when using their own eggs is not possible or has not resulted in successful treatment. This may include women with reduced ovarian reserve or premature ovarian insufficiency, patients who have experienced repeated unsuccessful IVF cycles, those affected by age-related changes in egg quality, and people who may require donor eggs for medical or genetic reasons.

Addressing the challenges of donor egg treatment

Choosing donor egg treatment is a significant decision, and for some patients the process can be complicated by donor availability, waiting times and the importance of finding a pathway that feels appropriate both medically and personally.

This can be particularly relevant for patients from South Asian backgrounds. Recent discussion from Alma Fertility and TMTC has highlighted the shortage of South Asian egg donors in the UK and the resulting challenges for patients seeking a donor who reflects their ethnic background.

The partnership between Alma Fertility and TMTC provides another option for patients who are considering international treatment.

Rather than asking patients to navigate an overseas fertility journey alone, the partnership is designed around a coordinated model of care.

UK-based fertility expertise, international treatment support

Under the partnership, patients begin their journey with Alma Fertility in London.

This includes an initial consultation, review of their fertility and medical history, appropriate assessment and discussion about whether donor egg treatment may be suitable for them. Counselling and emotional support can also form part of the preparation where appropriate.

If international treatment is considered appropriate, TMTC helps coordinate the treatment pathway in India, including donor coordination and clinic-based care.

The aim is to provide continuity throughout the process, with communication between the teams before, during and after treatment.

As a result, patients can make decisions about treatment with a clearer understanding of what is involved, rather than having to arrange every aspect of treatment overseas independently.

Why consider donor egg treatment in India?

There are a number of reasons why patients may explore fertility treatment internationally.

For some, it may be the availability of suitable donors. For others, it may be waiting times, treatment access, personal circumstances or the opportunity to explore treatment at a specialist partner clinic.

TMTC’s UK–India model is designed to combine UK-based fertility guidance with treatment delivered through partner clinics in India. TMTC states that its fertility pathways include treatment using both patients’ own and donor eggs, with patients receiving support before, during and after their treatment journey.

Importantly, international fertility treatment should not simply be viewed as a matter of travelling abroad for treatment. Patients need to understand the clinical, regulatory, legal, practical and emotional considerations involved.

That is why having experienced professionals involved before treatment begins can be so valuable.

A personalised approach to every patient

There is no single fertility pathway that is right for everyone.

For patients considering donor eggs, the decision can involve much more than medical treatment. There may be questions about donor screening, matching, genetic considerations, counselling, disclosure to a future child, treatment logistics and the emotional impact of donor conception.

Alma Fertility’s role is to help patients understand their individual circumstances and options before they make a decision.

The team can help patients prepare their medical and fertility history, review previous treatment and investigations, discuss donor matching and screening, and consider the practical and emotional aspects of treatment abroad.

Building a joined-up fertility journey

The new partnership reflects a growing need for fertility care that is both internationally connected and personally supported.

For patients, one of the biggest advantages of the Alma Fertility and TMTC pathway is continuity.

The journey can begin in London, with patients receiving personalised advice and assessment from the Alma Fertility team, before being connected with the treatment pathway in India through TMTC.

Following treatment, support continues as patients return to the UK.

This joined-up approach is designed to provide reassurance at every stage, while ensuring that patients understand what is happening and why.

Who might benefit from this pathway?

Donor egg treatment may be considered for a range of patients, including those who:

• Have reduced ovarian reserve or premature ovarian insufficiency
• Have experienced repeated unsuccessful IVF treatment
• Have concerns about age-related egg quality
• Have a medical or genetic reason for considering donor eggs
• Are looking for a wider range of donor options
• Are considering an international fertility treatment pathway

A consultation is an important first step because suitability for donor egg treatment depends on individual circumstances, medical history and fertility goals.

Supporting patients to make informed decisions

Fertility treatment can be an emotional journey, particularly when donor conception or international treatment is involved.

The partnership between Alma Fertility and TMTC is intended to make that journey more transparent and supported, giving patients the opportunity to ask questions, understand their options and consider treatment at their own pace.

For anyone considering donor egg treatment in India, the first step is not booking a flight. It is understanding whether the treatment is appropriate, what the pathway involves and what questions need to be answered before making a decision.

Alma Fertility and TMTC are bringing together UK and Indian expertise to help patients do exactly that.

About Alma Fertility

Alma Fertility provides personalised fertility care from its London clinic at Battersea Power Station. The team supports patients with fertility assessment, treatment planning and ongoing guidance throughout their fertility journey.

About TMTC

The Medical Travel Company (TMTC) connects patients in the UK with fertility treatment pathways in India, working with partner clinics and specialists to coordinate treatment and support before, during and after their journey.

Find out more

If you are considering donor egg treatment and would like to understand whether treatment in India could be an option for you, Alma Fertility can provide an initial consultation and explain the pathway in more detail.